✦ LIBER ✦

A prospective assessment of an ‘a la carte’ regimen of PEG-interferon alpha2b and ribavirin combination in patients with chronic hepatitis C using biochemical markers

✍ Scribed by C. D'Arondel; M. Munteanu; J. Moussalli; V. Thibault; S. Naveau; A. Simon; D. Messous; R. Morra; C. Blot; T. Poynard

Book ID: 108885830
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 93 KB
Volume: 13
Category: Article
ISSN: 1352-0504
DOI: 10.1111/j.1365-2893.2005.00668.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A case of polymyositis in a chronic hepa

A case of polymyositis in a chronic hepatitis C patient treated with peg-interferon-alpha 2b and ribavirin therapy

✍ Yusuke Okuma; Kiminori Kimura; Shunichi Saeki; Tsunekazu Hishima; Seishu Hayashi 📂 Article 📅 2009 🏛 Springer Japan 🌐 English ⚖ 244 KB

Is an “à la carte” combination interfero

Is an “à la carte” combination interferon alfa-2b plus ribavirin regimen possible for the first line treatment in patients with chronic hepatitis C?

✍ Thierry Poynard; John McHutchison; Zachary Goodman; Mei-Hsiu Ling; Janice Albrec 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 215 KB 👁 1 views

Randomized trials have shown the enhancement of efficacy with interferon alfa-2b and ribavirin (IFN-R) in comparison with interferon monotherapy (IFN) as first line treatment of chronic hepatitis C. Further definition of response based on disease, patient, and treatment characteristics is needed to

Changes in the Th1/Th2 ratio during a 24

Changes in the Th1/Th2 ratio during a 24-week course of an interferon alpha-2b plus ribavirin combination therapy for patients with chronic hepatitis C

✍ Tomoko Fujimoto; Masahiko Tomimatsu; Daijiro Iga; Hitoshi Endo; Kuniaki Otsuka 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 277 KB

Effective prediction of outcome of combi

Effective prediction of outcome of combination therapy with pegylated interferon alpha 2b plus ribavirin in Japanese patients with genotype-1 chronic hepatitis C using early viral kinetics and new indices

✍ Hideyuki Nomura; Yugo Miyagi; Hironori Tanimoto; Masashi Higashi; Hiromi Ishibas 📂 Article 📅 2009 🏛 Springer Japan 🌐 English ⚖ 391 KB

Daily dose of interferon alpha-2b and ri

Daily dose of interferon alpha-2b and ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection: a randomised controlled study

✍ GianPiero Benetti; Mauro Borzio; Giuliano Ramella; Giorgio Bellati; Silvia Fargi 📂 Article 📅 2006 🏛 Springer Milan 🌐 English ⚖ 98 KB

Predictors of alpha-fetoprotein elevatio

Predictors of alpha-fetoprotein elevation in patients with chronic hepatitis C, but not hepatocellular carcinoma, and its normalization after pegylated interferon alfa 2a–ribavirin combination therapy

✍ Tsung-Ming Chen; Pi-Teh Huang; Ming-Hung Tsai; Lien-Fu Lin; Chung-Cheng Liu; Ka- 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB